Diabetic neuropathy—the most common neuropathy in industrialized countries—encompasses a broad range of clinical manifestations. In this Review, Gérard Said discusses the clinical ...

This article describes the different conditions that embrace the diagnosis of diabetic neuropathies—the Cinderella complication of diabetes. Distinction between the proximal and distal large and ...

Clinical Aspects of Diabetic Neuropathy Length-dependent Diabetic Polyneuropathy More than 80% of patients with clinical diabetic neuropathy have a distal symmetrical form of the disorder. [6, 7 ...

Diabetes mellitus is the most common cause of neuropathy worldwide. In this review, the clinical, pathological and therapeutic aspects of various forms of diabetic neuropathy are discussed.

37 million Americans are living with diabetes and at least half of them struggle with a serious condition called diabetic neuropathy.

Zelira Therapeutics announced the publication of a clinical study demonstrating the efficacy and safety of its proprietary cannabinoid-based therapy, ZLT-L-007, in treating diabetic neuropathy.